[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 232 Introduced in House (IH)]

113th CONGRESS
  1st Session
                                H. R. 232

   To amend title XVIII of the Social Security Act to permit direct 
payment to pharmacies for certain compounded drugs that are prepared by 
the pharmacies for a specific beneficiary for use through an implanted 
                             infusion pump.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            January 14, 2013

  Mr. Harper introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
   To amend title XVIII of the Social Security Act to permit direct 
payment to pharmacies for certain compounded drugs that are prepared by 
the pharmacies for a specific beneficiary for use through an implanted 
                             infusion pump.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. MEDICARE DIRECT PAYMENT TO PHARMACIES FOR CERTAIN COMPOUNDED 
              DRUGS THAT ARE PREPARED BY THE PHARMACIES FOR A SPECIFIC 
              BENEFICIARY FOR USE THROUGH AN IMPLANTED INFUSION PUMP.

    (a) In General.--The first sentence of section 1842(b)(6) of the 
Social Security Act (42 U.S.C. 1395u(b)(6)) is amended--
            (1) by striking ``and'' before ``(H)''; and
            (2) by inserting before the period at the end the 
        following: ``, and (I) in the case of covered compounded drugs 
        that are prepared by a pharmacy for a specific individual, are 
        dispensed, directly or indirectly, to the individual, are 
        necessary for the effective use of, or therapeutic benefit 
        from, an implanted infusion pump (regardless of who refills the 
        pump), and are billed directly by the pharmacy, payment shall 
        be made to the pharmacy''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
apply to drugs dispensed on or after January 1, 2013.
                                 <all>